Sep 27, 2021

Low-cost blood test could diagnose Alzheimer’s up to 20 years before symptoms appear

To receive a diagnosis of Alzheimer’s disease today, doctors use cognitive tests, which only detect changes in the brain once symptoms are already present.

Professor Ralph Martins, Neurobiologist at Macquarie University Department of Biomedical Sciences Research, told HelloCare elevated levels of certain proteins in the blood are also an indicator of Alzheimer’s disease and can be picked up on brain scans.

However, the scans cost up to $3,000 each and the health system simply doesn’t have the capacity to screen whole populations.

But now a Macquarie University study has shown older adults with no cognitive deficits but whose brain scans reveal elevated levels of the proteins associated with Alzheimer’s disease also have higher levels of Alzheimer’s-related proteins in their blood compared with adults with normal brain scans. 

Due to improved technology, the Macquarie University study was able to identify minuscule levels of the proteins in the blood, a feat previously impossible because the volumes are so low.

Professor Martins said the new tool is 1,000 times more powerful than previous tools.

The study was funded by Anglicare, and 100 Anglicare retirement village residents took part.

All participants had no memory impairment. But scans revealed that one-third of the participants had high levels of amyloid in their brain, while two-thirds had “healthy” levels of the protein.

The highest level of accuracy (90%) was in the detection of green fluorescent protein (GFP), which makes it better than any other clinical method of diagnosing Alzheimer’s disease.

The study also looked at the participants after 12 months and found the levels of protein in the blood increased over time.

“So not only is it a diagnostic marker, we can also follow the progression of the disease,” Professor Martins said. “That’s what makes it even more exciting.”

Professor Martins believes the blood tests have the potential to provide a diagnosis of Alzheimer’s disease 15 to 20 years before symptoms appear.

There is currently only one drug treatment for Alzheimer’s disease, Aduhelm, which has been approved for use in the United States, but study results have been mixed. Some studies have shown the drug reduces the levels of protein in the brain, while others failed to show any benefit.

Nevertheless, the hope is that early intervention in the removal of amyloid proteins from the brain may prevent the disease from progressing.

The impact on the treatment of Alzheimer’s could be “huge”, he said.

Dr Pratishtha Chatterjee, lead author of the study and research fellow at Macquarie University Department of Biomedical Sciences Research, said, “These findings will allow more cost-effective screening and prognosis in clinical trials.”

Approximately 300,000 Australians currently have Alzheimer’s disease. There is no cure. The blood tests have the potential not only to provide early diagnosis and prevention of the onset of symptoms, they may also be used in the evaluation of drugs for treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. I live in perth. I have a strong family with 3 first degree relatives (all sisters) with AD. One has passed way with the disease. I have all of the test results showing ‘possible’ AD in other words – results unequivocle. I would like to have the blood test – is it posssible? How much will it cost??

Advertisement
Advertisement
Advertisement

Could casual aged care staff receive paid leave after groundbreaking court case?

The recent finding by the Federal Court that a casual mine worker was entitled to receive paid leave could have significant implications for the aged care sector, where 10 per cent of the residential aged care workforce is estimated to be employed on a casual basis. Across all of aged care, including home care, the... Read More

The “Alzheimer’s Solution”: Neurologists’ Plan to Protect People from the Early Symptoms of Dementia

Alzheimer’s disease and dementia is a growing condition in Australia, with more than 400,000 people and counting living with dementia. Currently around 244 people each day are joining the population with dementia. Dr Dean Sherzai And Dr Ayesha Sherzai are a husband-wife pair who have dedicated their lives to dementia and Alzheimer’s disease research. Together,... Read More

How do we promote access to the right care at the right time?

HelloCare Exclusive – part 3 in a series of 4. Read Part 1 and Part 2. The Aged Care Workforce Strategy, due to be delivered to the Minister for Aged Care, the Hon Ken Wyatt, at the end of this month, lays out pragmatic actions to grow and sustain the aged care workforce. The strategy... Read More
Advertisement
Exit mobile version